4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0000902664-21-001835
Director sold 806,000 shares at an average $39.99 ($32,228,827)
From the SEC's structured data for this filing
Trades in this filing
GOEL DAVID E. · Director
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-08 | Sale : show line 1 in the form | −234,295 | $38.22 | $8,954,310 | 12,880,795 | I |
| 2021-03-08 | Sale : show line 2 in the form | −75,000 | $39.22 | $2,941,163 | 12,805,795 | I |
| 2021-03-08 | Sale : show line 3 in the form | −33,600 | $39.97 | $1,343,039 | 12,772,195 | I |
| 2021-03-08 | Sale : show line 4 in the form | −71,194 | $41.21 | $2,933,641 | 12,701,001 | I |
| 2021-03-08 | Sale : show line 5 in the form | −85,911 | $41.62 | $3,575,753 | 12,615,090 | I |
| 2021-03-09 | Sale : show line 6 in the form | −215,698 | $40.42 | $8,719,333 | 12,399,392 | I |
| 2021-03-09 | Sale : show line 7 in the form | −34,302 | $41.16 | $1,411,887 | 12,365,090 | I |
| 2021-03-10 | Sale : show line 8 in the form | −25,732 | $41.47 | $1,067,037 | 12,339,358 | I |
| 2021-03-10 | Sale : show line 9 in the form | −30,268 | $42.38 | $1,282,664 | 12,309,090 | I |
| Open-market sales · 806,000 sh · avg $39.99 · $32,228,827 | ||||||
Loading xslF345X03/ownership.xml…